MLICM
GNLX icon

Metropolitan Life Insurance Company (MetLife)’s Genelux GNLX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,117
Closed -$15.6K – 2320
2023
Q4 		$15.6K Hold
1,117
– – ﹤0.01% 2022
2023
Q3 		$27.4K Buy
+1,117
New +$28.3K ﹤0.01% 1734

Other funds holding GNLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $388M AUM 20.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s GNLX Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Genelux (GNLX) in Q1 2024, closing a stake of 1,117 shares — an estimated $15.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in GNLX in Q3 2023 and held it in 2 quarters. The position peaked at $27.4K in Q3 2023. 67 funds tracked by Wall St. Rank hold GNLX as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Genelux position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,117 Genelux shares in Q1 2024, an estimated $15.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Genelux in Q3 2023 and held it in 2 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Genelux position peaked at $27.4K in Q3 2023.
  • 67 funds tracked by Wall St. Rank held Genelux as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.